IBRX (IBRX) Form 144 shows 25,000-share sale and prior 10b5-1 trades

Rhea-AI Filing Summary

A shareholder of IBRX has filed a Form 144 notice for a proposed sale of 25,000 shares of common stock through Morgan Stanley Smith Barney on the NASDAQ market. The filing lists an aggregate market value of $138,000 for these shares and an approximate sale date of 01/20/2026.

The shares to be sold were acquired on 01/20/2026 by exercising stock options granted by the issuer, with cash used as payment for the 25,000 shares. The issuer had 984,965,179 shares outstanding. The filing also discloses that during the prior three months, a Rule 10b5-1 trading plan for Christobel Selecky sold 50,000 common shares for $250,000 in gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	138000.00	984965179	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/20/2026	Exercise of Stock Options	Issuer			25000	01/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOBEL SELECKY 3530 John Hopkins Court San Diego CA 92121	Common	01/16/2026	50000	250000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many IBRX shares are covered by this Form 144 filing?

The Form 144 notice covers a proposed sale of 25,000 shares of IBRX common stock, with an aggregate market value of $138,000 as stated in the filing.

How and when were the IBRX shares to be sold under Form 144 acquired?

The 25,000 IBRX common shares were acquired on 01/20/2026 via an exercise of stock options from the issuer, with the purchase price paid in cash on the same date.

What trading arrangements and broker are used for this IBRX Form 144 sale?

The proposed sale of IBRX common stock is listed through Morgan Stanley Smith Barney LLC Executive Financial Services with trading on the NASDAQ exchange and an approximate sale date of 01/20/2026.

What IBRX share sales occurred in the past three months under a Rule 10b5-1 plan?

The filing reports 10b5-1 sales for Christobel Selecky of 50,000 IBRX common shares on 01/16/2026, generating $250,000 in gross proceeds.

How many IBRX shares were outstanding at the time of this Form 144 notice?

The Form 144 indicates that the issuer had 984,965,179 common shares outstanding when the 25,000-share proposed sale was reported.

What representation does the seller make in the IBRX Form 144 filing?

The person for whose account the IBRX securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.